Comparing Asthma Treatments: Salmeterol with Fluticasone vs. Fluticasone with Montelukast
Author Information
Author(s): Pavord Ian, Woodcock Ashley, Parker Debbie, Rice Leanne
Primary Institution: Glenfield Hospital, Leicester, UK
Hypothesis
What are the effects of salmeterol plus fluticasone propionate compared to fluticasone propionate plus montelukast on airway inflammation in asthma patients?
Conclusion
Both treatments led to similar control of eosinophilic airway inflammation, although PEF and symptom control were better with salmeterol plus fluticasone.
Supporting Evidence
- Both treatments improved airway responsiveness.
- SFC led to greater improvements in symptom control and lung function than FP/M.
- FP/M led to significantly greater reductions in sputum cysteinyl leukotrienes than SFC.
Takeaway
This study looked at two asthma treatments to see which one works better. Both helped, but one was better at making people feel good.
Methodology
A double-blind, placebo-controlled, parallel group study comparing two treatment combinations over 12 weeks.
Potential Biases
Potential bias due to the small sample size and exploratory nature of the study.
Limitations
The study was exploratory and based on a small sample size.
Participant Demographics
Adult asthmatics aged 18-50 years, non-smokers, requiring further therapy.
Statistical Information
P-Value
0.021
Confidence Interval
95% CI 1.09, 2.94
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website